Health Plus Care symposium presentation on the cost effectiveness of prescribing emollient therapy in dry skin and eczema

Overview of presentation

Johnson & Johnson Ltd have drawn upon CPRD data to weigh the cost to the NHS of prescribing emollients for eczema. This data was presented by Dr George Moncrieff and Mr Simon Rowe at the Health Plus Care Johnson & Johnson Ltd sponsored symposium at the ExCeL London, 28th June 2017.

The content of this video has been developed by Johnson & Johnson Ltd.  The views and opinions expressed in the animation are not necessarily those of Johnson & Johnson Ltd or MGP Ltd, its advisers, or advertisers.

 

For futher details about this presentation see the Guidelines in Practice website

 

Defining Cost & Clinical Outcomes in Dermatology (DECODE) 

DECODE is a cost effectiveness model from Johnson and Johnson Ltd that investigates the real value of emollient prescribing in UK primary care.

Email: decode@its.jnj.com to request more information or a visit from your local development manager

The guide on the DECODE model was developed, distributed, and produced by Johnson and Johnson Ltd.

If the PDF does not load within 5 seconds, please refresh the page.

 

 

Patient testimonials

UK/AV/18-11100

Date of preparation: March 2018

 

Best practice in eczema management sponsored by Johnson and Johnson Ltd